{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T04:35:57Z","timestamp":1794371757927,"version":"4.9.0"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2016,6,9]],"date-time":"2016-06-09T00:00:00Z","timestamp":1465430400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Wellcome Trust (GB)","award":["101786"],"award-info":[{"award-number":["101786"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1007\/s00109-016-1427-y","type":"journal-article","created":{"date-parts":[[2016,6,8]],"date-time":"2016-06-08T20:37:39Z","timestamp":1465418259000},"page":"739-746","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":494,"title":["Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders"],"prefix":"10.1007","volume":"94","author":[{"given":"Robert W.","family":"Mahley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,6,9]]},"reference":[{"key":"1427_CR1","doi-asserted-by":"crossref","unstructured":"Fredrickson DS, Levy RI, Lees RS (1967) Fat transport in lipoproteins\u2014an integrated approach to mechanisms and disorders. N Engl J Med 276: 34\u201344, 94\u2013103, 148\u2013156, 215\u2013225, 273\u2013281","DOI":"10.1056\/NEJM196701052760107"},{"key":"1427_CR2","doi-asserted-by":"crossref","unstructured":"Mahley RW (1988) Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240:622\u2013630","DOI":"10.1126\/science.3283935"},{"key":"1427_CR3","doi-asserted-by":"crossref","unstructured":"Shore VG, Shore B (1973) Heterogeneity of human plasma very low density lipoproteins. Separation of species differing in protein components. Biochemistry 12:502\u2013507","DOI":"10.1021\/bi00727a022"},{"key":"1427_CR4","doi-asserted-by":"crossref","unstructured":"Shore VG, Shore B, Hart RG (1974) Changes in apolipoproteins and properties of rabbit very low density lipoproteins on induction of cholesteremia. Biochemistry 13:1579\u20131585","DOI":"10.1021\/bi00705a004"},{"key":"1427_CR5","doi-asserted-by":"crossref","unstructured":"Mahley RW, Weisgraber KH, Innerarity T (1974) Canine lipoproteins and atherosclerosis. II. Characterization of the plasma lipoproteins associated with atherogenic and nonatherogenic hyperlipidemia. Circ Res 35:722\u2013733","DOI":"10.1161\/01.RES.35.5.722"},{"key":"1427_CR6","doi-asserted-by":"crossref","unstructured":"Mahley RW, Weisgraber KH, Innerarity T, Brewer HB Jr, Assmann G (1975) Swine lipoproteins and atherosclerosis. Changes in the plasma lipoproteins and apoproteins induced by cholesterol feeding. Biochemistry 14:2817\u20132823","DOI":"10.1021\/bi00684a005"},{"key":"1427_CR7","doi-asserted-by":"crossref","unstructured":"Mahley RW, Weisgraber KH, Innerarity T (1976) Atherogenic hyperlipoproteinemia induced by cholesterol feeding in the Patas monkey. Biochemistry 15:2979\u20132985","DOI":"10.1021\/bi00659a007"},{"key":"1427_CR8","doi-asserted-by":"crossref","unstructured":"Mahley RW (1985) Atherogenic lipoproteins and coronary artery disease: concepts derived from recent advances in cellular and molecular biology. Circulation 72:943\u2013948","DOI":"10.1161\/01.CIR.72.5.943"},{"key":"1427_CR9","doi-asserted-by":"crossref","unstructured":"Mahley RW, Innerarity TL, Rall SC Jr, Weisgraber KH (1984) Plasma lipoproteins: apolipoprotein structure and function. J Lipid Res 25:1277\u20131294","DOI":"10.1016\/S0022-2275(20)34443-6"},{"key":"1427_CR10","doi-asserted-by":"crossref","unstructured":"Zannis VI, Breslow JL, Utermann G, Mahley RW, Weisgraber KH, Havel RJ, Goldstein JL, Brown MS, Schonfeld G, Hazzard WR et al (1982) Proposed nomenclature of apoE isoproteins, apoE genotypes, and phenotypes. J Lipid Res 23:911\u2013914","DOI":"10.1016\/S0022-2275(20)38094-9"},{"key":"1427_CR11","doi-asserted-by":"crossref","unstructured":"Mahley RW, Rall SC Jr (2000) Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet 1:507\u2013537","DOI":"10.1146\/annurev.genom.1.1.507"},{"key":"1427_CR12","doi-asserted-by":"crossref","unstructured":"Mahley RW, Weisgraber KH, Huang Y (2009) Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer\u2019s disease to AIDS. J Lipid Res 50:S183\u2013S188","DOI":"10.1194\/jlr.R800069-JLR200"},{"key":"1427_CR13","doi-asserted-by":"crossref","unstructured":"Weisgraber KH (1994) Apolipoprotein E: structure\u2013function relationships. Adv Protein Chem 45:249\u2013302","DOI":"10.1016\/S0065-3233(08)60642-7"},{"key":"1427_CR14","doi-asserted-by":"crossref","unstructured":"Xu Q, Bernardo A, Walker D, Kanegawa T, Mahley RW, Huang Y (2006) Profile and regulation of apolipoprotein E (apoE) expression in the CNS in mice with targeting of green fluorescent protein gene to the apoE locus. J Neurosci 26:4985\u20134994","DOI":"10.1523\/JNEUROSCI.5476-05.2006"},{"key":"1427_CR15","doi-asserted-by":"crossref","unstructured":"Uchihara T, Duyckaerts C, He Y, Kobayashi K, Seilhean D, Amouyel P, Hauw J-J (1995) ApoE immunoreactivity and microglial cells in Alzheimer\u2019s disease brain. Neurosci Lett 195:5\u20138","DOI":"10.1016\/0304-3940(95)11763-M"},{"key":"1427_CR16","doi-asserted-by":"crossref","unstructured":"Boyles JK, Pitas RE, Wilson E, Mahley RW, Taylor JM (1985) Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J Clin Invest 76:1501\u20131513","DOI":"10.1172\/JCI112130"},{"key":"1427_CR17","doi-asserted-by":"crossref","unstructured":"Linton MF, Gish R, Hubl ST, B\u00fctler E, Esquivel C, Bry WI, Boyles JK, Wardell MR, Young SG (1991) Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation. J Clin Invest 88:270\u2013281","DOI":"10.1172\/JCI115288"},{"key":"1427_CR18","doi-asserted-by":"crossref","unstructured":"Wernette-Hammond ME, Lauer SJ, Corsini A, Walker D, Taylor JM, Rall SC Jr (1989) Glycosylation of human apolipoprotein E. The carbohydrate attachment site is threonine 194. J Biol Chem 264:9094\u20139101","DOI":"10.1016\/S0021-9258(18)81907-X"},{"key":"1427_CR19","doi-asserted-by":"crossref","unstructured":"Wilson C, Mau T, Weisgraber KH, Wardell MR, Mahley RW, Agard DA (1994) Salt bridge relay triggers defective LDL receptor binding by a mutant apolipoprotein. Structure 2:713\u2013718","DOI":"10.1016\/S0969-2126(00)00072-1"},{"key":"1427_CR20","doi-asserted-by":"crossref","unstructured":"Wilson C, Wardell MR, Weisgraber KH, Mahley RW, Agard DA (1991) Three-dimensional structure of the LDL receptor-binding domain of human apolipoprotein E. Science 252:1817\u20131822","DOI":"10.1126\/science.2063194"},{"key":"1427_CR21","unstructured":"Mahley RW, Rall SC Jr (2001) Type III hyperlipoproteinemia (dysbetalipoproteinemia): the role of apolipoprotein E in normal and abnormal lipoprotein metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, Kinzler KW, Vogelstein B (eds) The Metabolic and Molecular Bases of Inherited Disease. McGraw-Hill, New York, pp 2835\u20132862"},{"key":"1427_CR22","doi-asserted-by":"crossref","unstructured":"Mahley RW, Huang Y, Rall SC Jr (1999) Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia): questions, quandaries, and paradoxes. J Lipid Res 40:1933\u20131949","DOI":"10.1016\/S0022-2275(20)32417-2"},{"key":"1427_CR23","doi-asserted-by":"crossref","unstructured":"Dong L-M, Weisgraber KH (1996) Human apolipoprotein E4 domain interaction. Arginine 61 and glutamic acid 255 interact to direct the preference for very low density lipoproteins. J Biol Chem 271:19053\u201319057","DOI":"10.1074\/jbc.271.32.19053"},{"key":"1427_CR24","doi-asserted-by":"crossref","unstructured":"Dong L-M, Wilson C, Wardell MR, Simmons T, Mahley RW, Weisgraber KH, Agard DA (1994) Human apolipoprotein E. Role of arginine 61 in mediating the lipoprotein preferences of the E3 and E4 isoforms. J Biol Chem 269:22358\u201322365","DOI":"10.1016\/S0021-9258(17)31797-0"},{"key":"1427_CR25","doi-asserted-by":"crossref","unstructured":"Bennet AM, Di Angelantonio E, Ye Z, Wensley F, Dahlin A, Ahlbom A, Keavney B, Collins R, Wiman B, de Faire U et al (2007) Association of apolipoprotein E genotypes with lipid levels and coronary risk. JAMA 298:1300\u20131311","DOI":"10.1001\/jama.298.11.1300"},{"key":"1427_CR26","doi-asserted-by":"crossref","unstructured":"Gregg RE, Zech LA, Schaefer EJ, Stark D, Wilson D, Brewer HB Jr (1986) Abnormal in vivo metabolism of apolipoprotein E4 in humans. J Clin Invest 78:815\u2013821","DOI":"10.1172\/JCI112645"},{"key":"1427_CR27","doi-asserted-by":"crossref","unstructured":"Weintraub MS, Eisenberg S, Breslow JL (1987) Dietary fat clearance in normal subjects is regulated by genetic variation of apolipoprotein E. J Clin Invest 80:1571\u20131577","DOI":"10.1172\/JCI113243"},{"key":"1427_CR28","doi-asserted-by":"crossref","unstructured":"Li H, Dhanasekaran P, Alexander ET, Rader DJ, Phillips MC, Lund-Katz S (2013) Molecular mechanisms responsible for the differential effects of apoE3 and apoE4 on plasma lipoprotein\u2013cholesterol levels. Arterioscler Thromb Vasc Biol 33:687\u2013693","DOI":"10.1161\/ATVBAHA.112.301193"},{"key":"1427_CR29","doi-asserted-by":"crossref","unstructured":"Mahley RW, Ji Z-S (1999) Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E. J Lipid Res 40:1\u201316","DOI":"10.1016\/S0022-2275(20)33334-4"},{"key":"1427_CR30","doi-asserted-by":"crossref","unstructured":"Mahley RW, Huang Y (2007) Atherogenic remnant lipoproteins: role for proteoglycans in trapping, transferring, and internalizing. J Clin Invest 117:94\u201398","DOI":"10.1172\/JCI30889"},{"key":"1427_CR31","doi-asserted-by":"crossref","unstructured":"Ye S, Huang Y, M\u00fcllendorff K, Dong L, Giedt G, Meng EC, Cohen FE, Kuntz ID, Weisgraber KH, Mahley RW (2005) Apolipoprotein (apo) E4 enhances amyloid \u03b2 peptide production in cultured neuronal cells: apoE structure as a potential therapeutic target. Proc Natl Acad Sci U S A 102:18700\u201318705","DOI":"10.1073\/pnas.0508693102"},{"key":"1427_CR32","doi-asserted-by":"crossref","unstructured":"Xu Q, Brecht WJ, Weisgraber KH, Mahley RW, Huang Y (2004) Apolipoprotein E4 domain interaction occurs in living neuronal cells as determined by fluorescence resonance energy transfer. J Biol Chem 279:25511\u201325516","DOI":"10.1074\/jbc.M311256200"},{"key":"1427_CR33","doi-asserted-by":"crossref","unstructured":"Hatters DM, Budamagunta MS, Voss JC, Weisgraber KH (2005) Modulation of apolipoprotein E structure by domain interaction. Differences in lipid-bound and lipid-free forms. J Biol Chem 280:34288\u201334295","DOI":"10.1074\/jbc.M506044200"},{"key":"1427_CR34","doi-asserted-by":"crossref","unstructured":"Peters-Libeu CA, Newhouse Y, Hatters DM, Weisgraber KH (2006) Model of biologically active apolipoprotein E bound to dipalmitoylphosphatidylcholine. J Biol Chem 281:1073\u20131079","DOI":"10.1074\/jbc.M510851200"},{"key":"1427_CR35","doi-asserted-by":"crossref","unstructured":"Nguyen D, Dhanasekaran P, Nickel M, Nakatani R, Saito H, Phillips MC, Lund-Katz S (2010) Molecular basis for the differences in lipid and lipoprotein binding properties of human apolipoproteins E3 and E4. Biochemistry 49:10881\u201310889","DOI":"10.1021\/bi1017655"},{"key":"1427_CR36","doi-asserted-by":"crossref","unstructured":"Mahley RW, Huang Y (2012) Apolipoprotein E sets the stage: response to injury triggers neuropathology. Neuron 76:871\u2013885","DOI":"10.1016\/j.neuron.2012.11.020"},{"key":"1427_CR37","doi-asserted-by":"crossref","unstructured":"Huang Y, Mucke L (2012) Alzheimer mechanisms and therapeutic strategies. Cell 148:1204\u20131222","DOI":"10.1016\/j.cell.2012.02.040"},{"key":"1427_CR38","doi-asserted-by":"crossref","unstructured":"Mahley RW, Huang Y (2012) Small-molecule structure correctors target abnormal protein structure and function: the structure corrector rescue of apolipoprotein E-associated neuropathology. J Med Chem 55:8997\u20139008","DOI":"10.1021\/jm3008618"},{"key":"1427_CR39","doi-asserted-by":"crossref","unstructured":"Holtzman DM, Herz J, Bu G (2012) Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease. Cold Spring Harb Perspect Med 2:a006312","DOI":"10.1101\/cshperspect.a006312"},{"key":"1427_CR40","doi-asserted-by":"crossref","unstructured":"Bu G (2009) Apolipoprotein E and its receptors in Alzheimer\u2019s disease: pathways, pathogenesis and therapy. Nat Rev Neurosci 10:333\u2013344","DOI":"10.1038\/nrn2620"},{"key":"1427_CR41","doi-asserted-by":"crossref","unstructured":"Kim J, Basak JM, Holtzman DM (2009) The role of apolipoprotein E in Alzheimer\u2019s disease. Neuron 63:287\u2013303","DOI":"10.1016\/j.neuron.2009.06.026"},{"key":"1427_CR42","doi-asserted-by":"crossref","unstructured":"Campion D, Dumanchin C, Hannequin D, Dubois B, Belliard S, Puel M, Thomas-Anterion C, Michon A, Martin C, Charbonnier F et al (1999) Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum. Am J Hum Genet 65:664\u2013670","DOI":"10.1086\/302553"},{"key":"1427_CR43","doi-asserted-by":"crossref","unstructured":"Palop JJ, Mucke L (2010) Amyloid-\u03b2-induced neuronal dysfunction in Alzheimer\u2019s disease: from synapses toward neural networks. Nat Neurosci 13:812\u2013818","DOI":"10.1038\/nn.2583"},{"key":"1427_CR44","doi-asserted-by":"crossref","unstructured":"Bertram L, Lill CM, Tanzi RE (2010) The genetics of Alzheimer disease: back to the future. Neuron 68:270\u2013281","DOI":"10.1016\/j.neuron.2010.10.013"},{"key":"1427_CR45","doi-asserted-by":"crossref","unstructured":"Ashe KH, Zahs KR (2010) Probing the biology of Alzheimer\u2019s disease in mice. Neuron 66:631\u2013645","DOI":"10.1016\/j.neuron.2010.04.031"},{"key":"1427_CR46","doi-asserted-by":"crossref","unstructured":"Zahs KR, Ashe KH (2010) \u2018Too much good news\u2019\u2014are Alzheimer mouse models trying to tell us how to prevent, not cure, Alzheimer\u2019s disease? Trends Neurosci 33:381\u2013389","DOI":"10.1016\/j.tins.2010.05.004"},{"key":"1427_CR47","first-page":"1030","volume":"145","author":"T Wisniewski","year":"1994","unstructured":"Wisniewski T, Casta\u00f1o EM, Golabek A, Vogel T, Frangione B (1994) Acceleration of Alzheimer\u2019s fibril formation by apolipoprotein E in vitro. Am J Pathol 145:1030\u20131035","journal-title":"Am J Pathol"},{"key":"1427_CR48","doi-asserted-by":"crossref","first-page":"89ra57","DOI":"10.1126\/scitranslmed.3002156","volume":"3","author":"JM Castellano","year":"2011","unstructured":"Castellano JM, Kim J, Stewart FR, Jiang H, DeMattos RB, Patterson BW, Fagan AM, Morris JC, Mawuenyega KG, Cruchaga C et al (2011) Human apoE isoforms differentially regulate brain amyloid-\u03b2 peptide clearance. Sci Transl Med 3:89ra57","journal-title":"Sci Transl Med"},{"key":"1427_CR49","doi-asserted-by":"crossref","first-page":"23403","DOI":"10.1016\/S0021-9258(17)31529-6","volume":"269","author":"MJ LaDu","year":"1994","unstructured":"LaDu MJ, Falduto MT, Manelli AM, Reardon CA, Getz GS, Frail DE (1994) Isoform-specific binding of apolipoprotein E to \u03b2-amyloid. J Biol Chem 269:23403\u201323406","journal-title":"J Biol Chem"},{"key":"1427_CR50","doi-asserted-by":"crossref","first-page":"E1807","DOI":"10.1073\/pnas.1220484110","volume":"110","author":"PB Verghese","year":"2013","unstructured":"Verghese PB, Castellano JM, Garai K, Wang Y, Jiang H, Shah A, Bu G, Frieden C, Holtzman DM (2013) ApoE influences amyloid-\u03b2 (A\u03b2) clearance despite minimal apoE\/A\u03b2 association in physiological conditions. Proc Natl Acad Sci U S A 110:E1807\u2013E1816","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1427_CR51","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.bbalip.2010.02.010","volume":"1801","author":"R Koldamova","year":"2010","unstructured":"Koldamova R, Fitz NF, Lefterov I (2010) The role of ATP-binding cassette transporter A1 in Alzheimer\u2019s disease and neurodegeneration. Biochim Biophys Acta 1801:824\u2013830","journal-title":"Biochim Biophys Acta"},{"key":"1427_CR52","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.cmet.2014.01.003","volume":"19","author":"S Stukas","year":"2014","unstructured":"Stukas S, Robert J, Wellington Cheryl L (2014) High-density lipoproteins and cerebrovascular integrity in Alzheimer\u2019s disease. Cell Metab 19:574\u2013591","journal-title":"Cell Metab"},{"key":"1427_CR53","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/cvr\/cvu148","volume":"103","author":"C Vitali","year":"2014","unstructured":"Vitali C, Wellington CL, Calabresi L (2014) HDL and cholesterol handling in the brain. Cardiovasc Res 103:405\u2013413","journal-title":"Cardiovasc Res"},{"key":"1427_CR54","doi-asserted-by":"crossref","first-page":"34414","DOI":"10.1074\/jbc.M113.508812","volume":"288","author":"F Quazi","year":"2013","unstructured":"Quazi F, Molday RS (2013) Differential phospholipid substrates and directional transport by ATP-binding cassette proteins ABCA1, ABCA7, and ABCA4 and disease-causing mutants. J Biol Chem 288:34414\u201334426","journal-title":"J Biol Chem"},{"key":"1427_CR55","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1194\/jlr.M700481-JLR200","volume":"49","author":"BL Burgess","year":"2008","unstructured":"Burgess BL, Parkinson PF, Racke MM, Hirsch-Reinshagen V, Fan J, Wong C, Stukas S, Theroux L, Chan JY, Donkin J et al (2008) ABCG1 influences the brain cholesterol biosynthetic pathway but does not affect amyloid precursor protein or apolipoprotein E metabolism in vivo. J Lipid Res 49:1254\u20131267","journal-title":"J Lipid Res"},{"key":"1427_CR56","doi-asserted-by":"crossref","first-page":"9774","DOI":"10.1073\/pnas.0403506101","volume":"101","author":"N Wang","year":"2004","unstructured":"Wang N, Lan D, Chen W, Matsuura F, Tall AR (2004) ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins. Proc Natl Acad Sci U S A 101:9774\u20139779","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1427_CR57","doi-asserted-by":"crossref","first-page":"11445","DOI":"10.1523\/JNEUROSCI.1972-08.2008","volume":"28","author":"DR Riddell","year":"2008","unstructured":"Riddell DR, Zhou H, Atchison K, Warwick HK, Atkinson PJ, Jefferson J, Xu L, Aschmies S, Kirksey Y, Hu Y et al (2008) Impact of apolipoprotein E (apoE) polymorphism on brain apoE levels. J Neurosci 28:11445\u201311453","journal-title":"J Neurosci"},{"key":"1427_CR58","doi-asserted-by":"crossref","first-page":"25754","DOI":"10.1074\/jbc.M502143200","volume":"280","author":"JD Fryer","year":"2005","unstructured":"Fryer JD, DeMattos RB, McCormick LM, O\u2019Dell MA, Spinner ML, Bales KR, Paul SM, Sullivan PM, Parsadanian M, Bu G et al (2005) The low density lipoprotein receptor regulates the level of central nervous system human and murine apolipoprotein E but does not modify amyloid plaque pathology in PDAPP mice. J Biol Chem 280:25754\u201325759","journal-title":"J Biol Chem"},{"key":"1427_CR59","first-page":"671","volume":"118","author":"SE Wahrle","year":"2008","unstructured":"Wahrle SE, Jiang H, Parsadanian M, Kim J, Li A, Knoten A, Jain S, Hirsch-Reinshagen V, Wellington CL, Bales KR et al (2008) Overexpression of ABCA1 reduces amyloid deposition in the PDAPP mouse model of Alzheimer disease. J Clin Invest 118:671\u2013682","journal-title":"J Clin Invest"},{"key":"1427_CR60","doi-asserted-by":"crossref","first-page":"43243","DOI":"10.1074\/jbc.M508781200","volume":"280","author":"V Hirsch-Reinshagen","year":"2005","unstructured":"Hirsch-Reinshagen V, Maia LF, Burgess BL, Blain J-F, Naus KE, McIsaac SA, Parkinson PF, Chan JY, Tansley GH, Hayden MR et al (2005) The absence of ABCA1 decreases soluble apoE levels but does not diminish amyloid deposition in two murine models of Alzheimer disease. J Biol Chem 280:43243\u201343256","journal-title":"J Biol Chem"},{"key":"1427_CR61","doi-asserted-by":"crossref","first-page":"43224","DOI":"10.1074\/jbc.M504513200","volume":"280","author":"R Koldamova","year":"2005","unstructured":"Koldamova R, Staufenbiel M, Lefterov I (2005) Lack of ABCA1 considerably decreases brain apoE level and increases amyloid deposition in APP23 mice. J Biol Chem 280:43224\u201343235","journal-title":"J Biol Chem"},{"key":"1427_CR62","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.jalz.2015.04.006","volume":"11","author":"LT Nordestgaard","year":"2015","unstructured":"Nordestgaard LT, Tybj\u00e6rg-Hansen A, Nordestgaard BG, Frikke-Schmidt R (2015) Loss-of-function mutation in ABCA1 and risk of Alzheimer\u2019s disease and cerebrovascular disease. Alzheimers Dement 11:1430\u20131438","journal-title":"Alzheimers Dement"},{"key":"1427_CR63","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1001\/jamaneurol.2013.2152","volume":"70","author":"BV Zlokovic","year":"2013","unstructured":"Zlokovic BV (2013) Cerebrovascular effects of apolipoprotein E: implications for Alzheimer disease. JAMA Neurol 70:440\u2013444","journal-title":"JAMA Neurol"},{"key":"1427_CR64","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1212\/01.WNL.0000128091.92139.0F","volume":"62","author":"P Tiraboschi","year":"2004","unstructured":"Tiraboschi P, Hansen LA, Masliah E, Alford M, Thal LJ, Corey-Bloom J (2004) Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease. Neurology 62:1977\u20131983","journal-title":"Neurology"},{"key":"1427_CR65","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1212\/01.WNL.0000063311.58879.01","volume":"60","author":"P Giannakopoulos","year":"2003","unstructured":"Giannakopoulos P, Herrmann FR, Bussi\u00e8re T, Bouras C, K\u00f6vari E, Perl DP, Morrison JH, Gold G, Hof PR (2003) Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer\u2019s disease. Neurology 60:1495\u20131500","journal-title":"Neurology"},{"key":"1427_CR66","doi-asserted-by":"crossref","first-page":"5215","DOI":"10.1074\/jbc.M110.151084","volume":"286","author":"H-K Chen","year":"2011","unstructured":"Chen H-K, Ji Z-S, Dodson SE, Miranda RD, Rosenblum CI, Reynolds IJ, Freedman SB, Weisgraber KH, Huang Y, Mahley RW (2011) Apolipoprotein E4 domain interaction mediates detrimental effects on mitochondria and is a potential therapeutic target for Alzheimer disease. J Biol Chem 286:5215\u20135221","journal-title":"J Biol Chem"},{"key":"1427_CR67","doi-asserted-by":"crossref","first-page":"5253","DOI":"10.1074\/jbc.M111.276162","volume":"287","author":"H-K Chen","year":"2012","unstructured":"Chen H-K, Liu Z, Meyer-Franke A, Brodbeck J, Miranda RD, McGuire JG, Pleiss MA, Ji Z-S, Balestra ME, Walker DW et al (2012) Small molecule structure correctors abolish detrimental effects of apolipoprotein E4 in cultured neurons. J Biol Chem 287:5253\u20135266","journal-title":"J Biol Chem"},{"key":"1427_CR68","doi-asserted-by":"crossref","first-page":"8838","DOI":"10.1073\/pnas.151254698","volume":"98","author":"Y Huang","year":"2001","unstructured":"Huang Y, Liu XQ, Wyss-Coray T, Brecht WJ, Sanan DA, Mahley RW (2001) Apolipoprotein E fragments present in Alzheimer\u2019s disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons. Proc Natl Acad Sci U S A 98:8838\u20138843","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1427_CR69","doi-asserted-by":"crossref","first-page":"13707","DOI":"10.1523\/JNEUROSCI.4040-10.2010","volume":"30","author":"Y Andrews-Zwilling","year":"2010","unstructured":"Andrews-Zwilling Y, Bien-Ly N, Xu Q, Li G, Bernardo A, Yoon SY, Zwilling D, Yan TX, Chen L, Huang Y (2010) Apolipoprotein E4 causes age- and Tau-dependent impairment of GABAergic interneurons, leading to learning and memory deficits in mice. J Neurosci 30:13707\u201313717","journal-title":"J Neurosci"},{"key":"1427_CR70","doi-asserted-by":"crossref","first-page":"17217","DOI":"10.1074\/jbc.M110.217380","volume":"286","author":"J Brodbeck","year":"2011","unstructured":"Brodbeck J, McGuire J, Liu Z, Meyer-Franke A, Balestra ME, Jeong D-e, Pleiss M, McComas C, Hess F, Witter D et al (2011) Structure-dependent impairment of intracellular apolipoprotein E4 trafficking and its detrimental effects are rescued by small-molecule structure correctors. J Biol Chem 286:17217\u201317226","journal-title":"J Biol Chem"},{"key":"1427_CR71","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1126\/science.8171342","volume":"264","author":"BP Nathan","year":"1994","unstructured":"Nathan BP, Bellosta S, Sanan DA, Weisgraber KH, Mahley RW, Pitas RE (1994) Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science 264:850\u2013852","journal-title":"Science"},{"key":"1427_CR72","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1073\/pnas.0709906104","volume":"105","author":"J Brodbeck","year":"2008","unstructured":"Brodbeck J, Balestra ME, Saunders AM, Roses AD, Mahley RW, Huang Y (2008) Rosiglitazone increases dendritic spine density and rescues spine loss caused by apolipoprotein E4 in primary cortical neurons. Proc Natl Acad Sci U S A 105:1343\u20131346","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1427_CR73","doi-asserted-by":"crossref","first-page":"4867","DOI":"10.1523\/JNEUROSCI.19-12-04867.1999","volume":"19","author":"M Buttini","year":"1999","unstructured":"Buttini M, Orth M, Bellosta S, Akeefe H, Pitas RE, Wyss-Coray T, Mucke L, Mahley RW (1999) Expression of human apolipoprotein E3 or E4 in the brains of Apoe \u2013\/\u2013 mice: isoform-specific effects on neurodegeneration. J Neurosci 19:4867\u20134880","journal-title":"J Neurosci"},{"key":"1427_CR74","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/35006165","volume":"404","author":"J Raber","year":"2000","unstructured":"Raber J, Wong D, Yu G-Q, Buttini M, Mahley RW, Pitas RE, Mucke L (2000) Apolipoprotein E and cognitive performance. Nature 404:352\u2013354","journal-title":"Nature"},{"key":"1427_CR75","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0040555","volume":"7","author":"Y Andrews-Zwilling","year":"2012","unstructured":"Andrews-Zwilling Y, Gillespie AK, Kravitz AV, Nelson AB, Devidze N, Lo I, Yoon SY, Bien-Ly N, Ring K, Zwilling D et al (2012) Hilar GABAergic interneuron activity controls spatial learning and memory retrieval. PLoS ONE 7, e40555","journal-title":"PLoS ONE"},{"key":"1427_CR76","doi-asserted-by":"crossref","first-page":"10966","DOI":"10.1073\/pnas.1434398100","volume":"100","author":"FM Harris","year":"2003","unstructured":"Harris FM, Brecht WJ, Xu Q, Tesseur I, Kekonius L, Wyss-Coray T, Fish JD, Masliah E, Hopkins PC, Scearce-Levie K et al (2003) Carboxyl-terminal-truncated apolipoprotein E4 causes Alzheimer\u2019s disease-like neurodegeneration and behavioral deficits in transgenic mice. Proc Natl Acad Sci U S A 100:10966\u201310971","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1427_CR77","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1523\/JNEUROSCI.4315-03.2004","volume":"24","author":"WJ Brecht","year":"2004","unstructured":"Brecht WJ, Harris FM, Chang S, Tesseur I, Yu G-Q, Xu Q, Fish JD, Wyss-Coray T, Buttini M, Mucke L et al (2004) Neuron-specific apolipoprotein E4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice. J Neurosci 24:2527\u20132534","journal-title":"J Neurosci"},{"key":"1427_CR78","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1523\/JNEUROSCI.3253-07.2008","volume":"28","author":"Q Xu","year":"2008","unstructured":"Xu Q, Walker D, Bernardo A, Brodbeck J, Balestra ME, Huang Y (2008) Intron-3 retention\/splicing controls neuronal expression of apolipoprotein E in the CNS. J Neurosci 28:1452\u20131459","journal-title":"J Neurosci"},{"key":"1427_CR79","doi-asserted-by":"crossref","first-page":"18694","DOI":"10.1073\/pnas.0508254102","volume":"102","author":"S Chang","year":"2005","unstructured":"Chang S, Ma TR, Miranda RD, Balestra ME, Mahley RW, Huang Y (2005) Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity. Proc Natl Acad Sci U S A 102:18694\u201318699","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1427_CR80","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/a0bb886d-d345-4a20-a82e-adce9b047798","volume":"6","author":"PB Jones","year":"2011","unstructured":"Jones PB, Adams KW, Rozkalne A, Spires-Jones TL, Hshieh TT, Hashimoto T, von Armin CAF, Mielke M, Bacskai BJ, Hyman BT (2011) Apolipoprotein E: isoform specific differences in tertiary structure and interaction with amyloid-\u03b2 in human Alzheimer brain. PLoS ONE 6, e14586","journal-title":"PLoS ONE"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-016-1427-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00109-016-1427-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-016-1427-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T03:05:49Z","timestamp":1656644749000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00109-016-1427-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,9]]},"references-count":80,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["1427"],"URL":"https:\/\/doi.org\/10.1007\/s00109-016-1427-y","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,9]]}}}